Trial intelligence / Profile preview

Safety of Hydrocodone ER in Chronic Low Back Pain Extension Study

NCT01922739Phase 3Completed

Sponsor
Teva Pharmaceutical Industries Ltd.
Start
Jul 2013
Primary completion
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of hydrocodone in chronic low back pain (CLBP), sponsored by Teva Pharmaceutical Industries Ltd.. Started Jul 2013; status: completed.

02

Drugs

hydrocodone
03

Conditions

chronic low back pain (CLBP)

Beyond the preview

Go deeper on NCT01922739.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01922739.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call